Gilead Sciences India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 87.27%
- Profit Growth 91.11%
- Ebitda 139.54%
- Net Worth 23.48%
- Total Assets 15.68%
About Gilead Sciences India
Gilead Sciences India Private Limited (GSIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 26 July 2014 and has a history of Ten years and six months. Its registered office is in Delhi, India.
The Corporate was formerly known as Gsi Pharma Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Bargaje, Hans Stucker, and Janet Dorling serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74120DL2014FTC308398
-
Company No.
308398
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
26 Jul 2014
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gilead Sciences India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Bargaje
|
Director | 10-Jan-2018 | Current |
Hans Stucker
|
Director | 08-Aug-2023 | Current |
Janet Dorling
|
Director | 08-Aug-2023 | Current |
Financial Performance of Gilead Sciences India.
Gilead Sciences India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 87.27% increase. The company also saw a substantial improvement in profitability, with a 91.11% increase in profit. The company's net worth Soared by an impressive increase of 23.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gilead Sciences India?
In 2023, Gilead Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gilead Sciences India?
Unlock and access historical data on people associated with Gilead Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gilead Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gilead Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
